today emerged from stealth with $150 million in combined Series A financing from founding investor Versant Ventures and Novartis AG, as well as committed strategic research collaboration funding ...

Versant and Novartis joined forces in 2019 on ... The Swiss biotech emerged with $110 million in funding, $80 million from AZ, and a mission to develop a new generation of weight-loss therapies ...

Novartis has partnered with Versant Ventures to establish Borealis ... Novartis will offer upfront plus near-term research funding of up to $100, and holds the option for the acquisition of ...

It’s perhaps unsurprising that both Novartis and Versant want to repeat the success of Chinook. It only took a few months after the Big Pharma’s acquisition for Chinook’s oral endothelin A ...